Hilary Osborne’s piece (When it arrives to cancer drug aspect-results, it is about what you will tolerate to remain alive, 17 March) rang a lot of bells with me. Since autumn 2021, I have been taken care of for a next time for acute myeloid leukaemia, possessing experienced an uncommon return of the illness immediately after much more than 20 yrs without the need of indications.

Though my chemotherapy was a milder routine than ahead of, adjusted to my now becoming in my late 70s, I experienced more intense aspect-effects, particularly in the early levels of therapy. I had long-term gout and inflammation in my decreased legs so I had to use a walking frame, and I formulated deep vein thrombosis. These are equally recognised dangers of chemotherapy. The tiredness I recognised from all individuals yrs ago – it is in a league of its very own and stops any action promptly.

Despite the fact that I finished the chemotherapy months back, my hair is not rising. Additional importantly, my marketing consultant tells me that my lower platelet count, which means my blood has problems clotting and I bruise quickly, could be long lasting – a “battle scar” from chemotherapy.

Like Hilary, I am overwhelmingly grateful to however be alive and for all the fantastic treatment that I have had from the NHS – from my GP surgical treatment to my medical center remedy – but I think everybody hopes for a kinder cure.
Jennifer Rees

Like Hilary Osborne and tens of thousands of many others, I also am working with the side-consequences of these impressive but important medicine. Mine include mildly hallucinogenic desires, really imaginative (I think), not a jot of which can I recall in the early morning. How did rock musicians do it? Hugs and most effective needs to Hilary and all the other individuals in our not quite exceptional club.
Ken Foote

Have an feeling on anything you have read through in the Guardian nowadays? Remember to electronic mail us your letter and it will be considered for publication in our letters portion.

Leave a Reply